Generated by GPT-5-mini| Japanese Pharmacological Society | |
|---|---|
| Name | Japanese Pharmacological Society |
| Formation | 1929 |
| Type | Learned society |
| Headquarters | Tokyo |
| Leader title | President |
Japanese Pharmacological Society
The Japanese Pharmacological Society is a professional scholarly organization based in Tokyo that promotes research in pharmacology and therapeutics. Founded in the early 20th century, the society has intersected with institutions such as the University of Tokyo, Kyoto University, Osaka University, and Keio University while engaging researchers associated with the Ministry of Health, Labour and Welfare and international organizations like the World Health Organization and the International Union of Basic and Clinical Pharmacology. Its members include investigators linked to the RIKEN Institute, National Cancer Center, and pharmaceutical firms such as Takeda Pharmaceutical Company, Astellas Pharma, and Otsuka Pharmaceutical.
The society emerged in an era shaped by scientific developments at the Imperial University system, following precedents set by societies including the Royal Society and the American Society for Pharmacology and Experimental Therapeutics. Early leaders had affiliations with institutions like Tokyo Imperial University, Kyoto Imperial University, and the Yamagata Prefectural agricultural and medical schools; notable contemporaries included researchers from the Pasteur Institute, Max Planck Society, and Institut Pasteur. During the Shōwa period the society navigated connections with the Imperial Household Agency, the Japan Society for the Promotion of Science, and research centers such as the National Institute of Health Sciences and the Japan Agency for Medical Research and Development. Postwar reconstruction brought collaborations with global entities like the National Institutes of Health, the European Medicines Agency, and the Wellcome Trust, and engagements with scientific meetings akin to those of the Royal Society of Chemistry and the American Association for the Advancement of Science.
The society advances pharmacology through collaboration with universities such as Hokkaido University and Tohoku University, research institutes like the Salk Institute and Cold Spring Harbor Laboratory, and governmental science panels linked to the Cabinet Office. Its activities parallel programs run by organizations such as the Japan Society for the Promotion of Science, the Japan Medical Association, and the Pharmaceutical Society of Japan, and it liaises with patient-advocacy groups and agencies like the Japan Blood Products Organization. Through partnerships with foundations including the Rockefeller Foundation, the Wellcome Trust, and the Gates Foundation, the society supports translational initiatives involving clinical centers such as St. Luke's International Hospital, Kyoto Prefectural University of Medicine, and the National Cerebral and Cardiovascular Center.
Membership encompasses faculty from institutions like Keio University School of Medicine, Nagoya University, and Chiba University, clinical researchers at St. Marianna University School of Medicine, and industry scientists from Eisai, Daiichi Sankyo, and Mitsubishi Chemical. Governance structures mirror those of learned societies such as the Royal Society, the National Academy of Sciences, and the American Physiological Society, with elected officers and committees responsible for ethics, awards, and international relations. The society confers honors similar in function to the Lasker Award, the Japan Prize, and the Gairdner Foundation awards and coordinates accreditation and training linked to medical schools including Juntendo University and Tokyo Medical and Dental University.
The society publishes journals and bulletins comparable to the Journal of Pharmacology and Experimental Therapeutics, the British Journal of Pharmacology, and Clinical Pharmacology & Therapeutics, and collaborates with publishers and indexing services such as Elsevier, Wiley, Springer Nature, PubMed, and Scopus. It organizes annual meetings and symposia analogous to conferences held by the International Union of Basic and Clinical Pharmacology, the American Society for Clinical Pharmacology and Therapeutics, and the Federation of European Pharmacological Societies, hosting plenaries with speakers from institutions like Harvard Medical School, Stanford University School of Medicine, and the University of Cambridge. Special sessions have explored themes connected to regulatory frameworks managed by the Pharmaceuticals and Medical Devices Agency and comparative programs at the European Medicines Agency and the Food and Drug Administration.
Educational outreach includes workshops and training programs modeled on initiatives by the World Health Organization, the International Council for Harmonisation, and the Global Fund, and it partners with graduate programs at institutions such as Osaka City University, Kobe University, and Kyushu University. Research priorities reflect advances in molecular pharmacology, neurosciences at RIKEN Brain Science Institute, oncology collaborations with the National Cancer Center, and drug-discovery efforts linked to biotech hubs like Tsukuba Science City and Yokohama Bay Area. The society supports young investigators via grant schemes akin to those from the Japan Society for the Promotion of Science and fellowship exchanges with centers including the NIH Clinical Center, EMBL, and the Pasteur Institute.
Category:Medical associations based in Japan Category:Pharmacology organizations Category:Scientific societies in Japan